Contract 75N93021C00022
Spero Therapeutics, Inc. · Department Of Health And Human Services · July 11, 2024
Spero Therapeutics, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 11, 2024 for $3.42 million of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Cambridge, MA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses cost-plus contract pricing. The most recent modification was on August 23, 2024. If all options are exercised, the contract could reach $27.03 million.
Contract details
- PIID
- 75N93021C00022
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Cambridge, MA
- First action
- July 11, 2024
- Latest action
- August 23, 2024
Description
TO ADVANCE CLINICAL AND NON-CLINICAL DEVELOPMENT OF AN ANTIBIOTIC CANDIDATE.
Modification timeline
-
August 23, 2024Mod P00012 · Funding Only Action$10.50M
-
July 31, 2024Mod P00011 · Other Administrative Action$7.08M
-
July 11, 2024Mod P00010 · Other Administrative Action$7.08M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| The Emmes Company, Llc | Department Of Health And Human Services | April 1, 2026 | $771.5K |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $8.00M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $9.22M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $327.13M |
| The Brain Donor Project, Inc | Department Of Health And Human Services | April 1, 2026 | $1.27M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $20.43M |
Top contractors in NAICS 541715
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Fluor Marine Propulsion, Llc | 2 | $2.75B |
| 2 | California Institute Of Technology | 240 | $979.40M |
| 3 | The Johns Hopkins University Applied Physics Laboratory Llc | 204 | $482.74M |
| 4 | Lockheed Martin Corporation | 4 | $461.91M |
| 5 | Lockheed Martin Corp | 9 | $317.27M |
| 6 | The Aerospace Corporation | 85 | $308.18M |
| 7 | Fermi Forward Discovery Group, Llc | 1 | $289.92M |
| 8 | Lockheed Martin Corp | 7 | $285.45M |
| 9 | Amentum Technology, Inc. | 4 | $253.24M |
| 10 | The Mitre Corporation | 50 | $222.51M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93021C00022?
Contract 75N93021C00022 is a federal contract awarded to Spero Therapeutics, Inc. by Department Of Health And Human Services on July 11, 2024 for $3.42 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75N93021C00022?
Spero Therapeutics, Inc. won contract 75N93021C00022 from Department Of Health And Human Services.
How much is contract 75N93021C00022 worth?
Contract 75N93021C00022 has obligated $3.42 million to date, with a total potential value of $27.03 million if all options are exercised.